Stephen Schultz | Vice President, Investor Relations |
Justin Gover | Chief Executive Officer |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
Julian Gangolli | President, North America |
Salveen Richter | Goldman Sachs |
Paul Matteis | Leerink Partners |
Mark Fram | Cowen & Company |
Josh Schimmer | Evercore ISI |
Tazeen Ahmad | BOA |
Greetings and welcome to the GW Pharmaceuticals' First Quarter 2018 Financial Results Conference Call. At this time all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Stephen Schultz, Vice President of Investor Relations.